Scaling Up Cancer Care Access Globally

Equipment forms the 'body' of cancer care, while medical physicists and radiation oncologists serve as its 'brain,' ensuring its effective and safe operation. For instance, even a minimal 5% error in beam calibration can lead to critical under- or over-irradiation of patients, highlighting the need for expert oversight.

Providing sophisticated equipment without adequately trained personnel is akin to acquiring a high-performance racing car without a skilled driver, rendering the investment inefficient and potentially hazardous. Furthermore, training conducted in the native language of healthcare professionals significantly reduces errors and boosts confidence, directly impacting patient safety and treatment outcomes.

This holistic approach ensures that technological advancements are complemented by the human expertise necessary for optimal and safe cancer treatment delivery.

This program has systematically moved from initial facility preparation and technology installation to comprehensive staff training, establishing a sustainable national capacity for advanced cancer treatment.

A key aspect of this success is the provision of high-dose rate brachytherapy free of charge to women with cervical cancer within the Syrian public health system. This ensures equitable access to critical treatment, reflecting a commitment to broad public health benefits beyond mere equipment delivery.

Before this expansion, public mammography services were non-existent prior to 2018, and between 2018 and 2024, they were confined exclusively to the capital, Georgetown.

Since the implementation of these four new units in 2025, access to diagnostic screenings has dramatically expanded, resulting in 950 screenings within two years. This strategic decentralization has directly contributed to a notable improvement in public health outcomes.

Consequently, breast cancer's ranking in Guyana has fallen from the number one cause of cancer to the third position, underscoring the profound impact of broadened diagnostic access.

This process relies on three essential pillars: robust infrastructure, adequate human resources, and reliable equipment.

Effective procurement strategies must integrate service warranties to guarantee equipment uptime, which is crucial for minimizing treatment delays. Moreover, strategic facility planning is necessary to accommodate growing patient volumes and prevent bottlenecks in the treatment pathway.

Streamlining these elements ensures that patients receive timely care, improving treatment outcomes and overall system efficiency.

Economic data, combined with the lived experiences of patients, provides the most effective tool to persuade policymakers of the urgency and necessity of intervention. Financial experts and patients collaboratively construct this comprehensive case.

Patient stories must be integrated with thorough financial analysis to illustrate the tangible and hidden costs associated with treatment delays and inadequate care. This includes factoring in social determinants of health such as transportation and housing, which significantly impact patient outcomes and economic burdens.

Civil society organizations require training to effectively frame this data for policy advocacy, while the IAEA and UIC collaborate to strengthen these vital efforts, ensuring that data-driven arguments are presented clearly and persuasively.

Firstly, as a manufacturer, the company focuses on developing new technologies and equipment that deliver high-image quality products, thereby expanding access to accurate early diagnoses.

Secondly, Fujifilm prioritizes providing training and knowledge transfer to healthcare professionals, ensuring they are proficient in utilizing new technologies. Lastly, the company commits to ensuring sustainable support for its equipment and services, extending beyond the initial delivery to guarantee long-term operational efficiency.

This new approach involves extensive simulation environments where physicists can conduct measurements, make and analyze mistakes, and correct them under supervision before treating actual patients.

This method moves away from relying solely on individual experts and instead focuses on building a robust chain of trainers capable of imparting standardized safety protocols. Continuous education initiatives are standardizing these protocols across the region, fostering a more secure and efficient radiotherapy practice.

IMPACT reviews are crucial for countries with limited resources, enabling them to identify and prioritize critical needs within cancer care. These reviews ensure that scarce resources are strategically allocated to maximize their impact.

The focus is on optimizing the synergy among people, infrastructure, and equipment placement, ensuring that investments yield the greatest benefit. This strategic approach helps channel resources precisely where they can create the most significant improvements in cancer care delivery.

Historically, training materials were physically shipped from Vienna, primarily in book format, making access cumbersome.

The new online platform is now readily accessible to doctors, physicists, and nurses globally, providing a more efficient and flexible learning experience. Participants who complete the program earn an IAEA-accredited certificate, which serves as a benchmark for local competence. This program employs a hybrid model, integrating local mentors with distant tutors to facilitate comprehensive learning and practical application.

This fund, initiated through the Ministry of Health, supports ongoing and new cancer initiatives across the country.

The nation is also actively forging international partnerships, notably with South Korea and the IAEA. The IAEA provides crucial support through various Technical Cooperation (TC) projects, focusing on radiotherapy, imaging, and nuclear medicine, including the deployment of the first SPECT gamma camera.

Further enhancing its human resources, Côte d'Ivoire launched a new nuclear medicine diploma program this year, enrolling 16 students to build local expertise.

This intricate process spans from the production in reactors and cyclotrons to processing in GMP-certified facilities before reaching the patient. Before a radiopharmaceutical can even reach a patient, a long supply chain with many involved actors must be navigated.

Hospitals must be duly licensed and adequately equipped with advanced diagnostic tools such as PET/SPECT scanners to effectively utilize these materials. A critical gap in this chain is the persistent shortage of qualified personnel, which underscores the urgent need for enhanced training and robust maintenance programs across all levels.

The IAEA is actively addressing the escalating demand for Actinium-225 and navigating the regulatory complexities inherent in its distribution, striving to streamline and secure this vital supply chain.

The effectiveness of pediatric radiotherapy hinges on a systemic approach that extends beyond merely having access to machines. Safely and effectively treating children requires not only appropriate technology but also highly trained expertise, multidisciplinary decision-making, pediatric-specific knowledge, and rigorous quality assurance.

In many low and middle-income countries, pediatric expertise is unevenly distributed, posing a significant challenge. To address this, the IAEA is implementing a multidisciplinary competency framework and developing new quality assurance tools based on the QUATRO methodology. Additionally, a 'train the trainer' model ensures that the benefits of specialized training propagate widely, extending beyond individual practitioners to strengthen regional capabilities.

It is important to remember that most individuals treating children also treat adults, which often spreads their expertise thin across various patient populations.

To address this, the focus is shifting towards developing strong regional centers that will serve as training and mentoring hubs. A significant milestone was the pediatric radiotherapy workshop held in Sao Paulo, which successfully engaged 50 participants, marking a concrete step towards this scalable model.

Researchers have developed an AI-driven system that drastically reduces the time required for radiotherapy treatment planning. This innovative system can complete an entire treatment plan within one second from the moment the planning scan is performed. This includes segmenting all normal structures and target areas, optimizing the plan, and performing quality assurance.

This technology is proposed as a disruptive innovation, particularly for low and middle-income countries. It aims to bypass critical clinician shortages by automating complex planning processes, thereby accelerating access to treatment and improving efficiency.

The reimbursement structure in the United States currently incentivizes slower, multi-day radiotherapy treatment planning processes. Healthcare providers are paid less if they complete all planning activities on the same day as the patient's consultation.

This financial model leads many practices to separate tasks across multiple days to maximize billing. Consequently, disruptive technologies like AI, which can complete planning within seconds, may face slower adoption in the US compared to regions where reimbursement structures do not penalize efficiency.

Effective policy improvements require translating complex clinical needs into language that lawmakers can readily understand and act upon.

There is a proposal to take teaching efforts directly into houses of representatives and senates, ensuring that those who control funding and policy are well-informed. This direct engagement aims to foster greater legislative support and accelerate the implementation of vital cancer care initiatives.

True success is measured by operational performance and long-term impact rather than just initial delivery.

Four key factors are crucial for achieving sustainability: continuous education and training for personnel, robust service and maintenance frameworks for equipment, reliable digital connectivity to support operations, and stringent quality assurance protocols. Addressing these factors ensures that technological investments translate into lasting improvements in healthcare delivery.

While the recommendations are deemed excellent, they remain ineffective unless actively put into practice.

Crucial updates to SSR-6 regulations, particularly concerning half-emitting radionuclides used in clinical trials, are required. These updates are vital for ensuring the safe and efficient transport of materials essential for cancer diagnostics and treatment.

Despite the working group's mandate concluding, the imperative remains for these well-formulated recommendations to translate into tangible changes in operational procedures and regulatory frameworks.

Subpar image quality can lead to misdiagnosis or incorrect staging of diseases, which is critical since pathology evolves rapidly.

For example, if an image lacks clear quality, distinguishing not only dimensions and locations but also tissue types becomes impossible, leading to missed diagnoses. This underscores the necessity for high-quality images, especially when imaging is complemented by other modalities like ultrasound.

The swift evolution of pathology necessitates immediate and accurate imaging to ensure effective patient management. Therefore, multidisciplinary team approaches are essential to achieve optimal medical physics outcomes and ensure diagnostic precision.

This momentum is attributed to ongoing collaborations, innovative solutions, and shared commitment among partners. The next session is scheduled for 15:45, indicating continued engagement and strategic planning.